Standard InChI: InChI=1S/C29H34N4O2/c1-5-32(6-2)28(34)22-12-17-27-26(20-22)31-29(33(27)19-18-21(3)4)30-23-13-15-25(16-14-23)35-24-10-8-7-9-11-24/h7-17,20-21H,5-6,18-19H2,1-4H3,(H,30,31)
1.Dolles D, Hoffmann M, Gunesch S, Marinelli O, Möller J, Santoni G, Chatonnet A, Lohse MJ, Wittmann HJ, Strasser A, Nabissi M, Maurice T, Decker M.. (2018) Structure-Activity Relationships and Computational Investigations into the Development of Potent and Balanced Dual-Acting Butyrylcholinesterase Inhibitors and Human Cannabinoid Receptor 2 Ligands with Pro-Cognitive in Vivo Profiles., 61 (4):[PMID:29400965][10.1021/acs.jmedchem.7b01760]
2.Mangiatordi GF, Intranuovo F, Delre P, Abatematteo FS, Abate C, Niso M, Creanza TM, Ancona N, Stefanachi A, Contino M.. (2020) Cannabinoid Receptor Subtype 2 (CB2R) in a Multitarget Approach: Perspective of an Innovative Strategy in Cancer and Neurodegeneration., 63 (23.0):[PMID:33094613][10.1021/acs.jmedchem.0c01357]